Guangzhou LBP Medicine Science & Technology Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 207.26 million compared to CNY 235.23 million a year ago. Revenue was CNY 210.95 million compared to CNY 242.53 million a year ago.

Net income was CNY 18.1 million compared to CNY 35.21 million a year ago. Basic earnings per share from continuing operations was CNY 0.19 compared to CNY 0.38 a year ago. Diluted earnings per share from continuing operations was CNY 0.19 compared to CNY 0.38 a year ago.